Niall P. Quinn < Niall Quinn < Nicholas A. Di Prospero

Facettes :

List of bibliographic references indexed by Niall Quinn

Number of relevant bibliographic references: 8.

Ident.	Authors (with country if any)	Title
001098 (2007)	Murat Emre [Turquie] ; Dag Aarsland [Norvège] ; Richard Brown [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Charles Duyckaerts [France] ; Yoshikino Mizuno [Japon] ; Gerald Anthony Broe [Australie] ; Jeffrey Cummings [États-Unis] ; Dennis W. Dickson [États-Unis] ; Serge Gauthier [Canada] ; Jennifer Goldman [États-Unis] ; Christopher Goetz [États-Unis] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Ian Mckeith [Royaume-Uni] ; Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; Christina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Bruno Dubois [France]	Clinical diagnostic criteria for dementia associated with Parkinson's disease
001461 (2005)	Naheed L. Khan ; Shushant Jain ; John M. Lynch ; Nicola Pavese ; Patrick Abou-Sleiman ; Janice L. Holton ; Daniel G. Healy ; William P. Gilks ; Mary G. Sweeney ; Milan Ganguly ; Vaneesha Gibbons ; Sonia Gandhi ; Jenny Vaughan ; Louise H. Eunson ; Regina Katzenschlager ; Juliet Gayton ; Graham Lennox ; Tamas Revesz ; David Nicholl [Royaume-Uni] ; Kailash P. Bhatia ; Niall Quinn ; David Brooks ; Andrew Lees (neurologue) [Royaume-Uni] ; Mary B. Davis ; Paola Piccini ; Andrew B. Singleton [États-Unis] ; Nicholas W. Wood	Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data
001481 (2005)	Mark Stacy [États-Unis] ; Annette Bowron [Royaume-Uni] ; Mark Guttman [Canada] ; Robert Hauser [États-Unis] ; Kim Hughes [Royaume-Uni] ; Jan Petter Larsen [Norvège] ; Peter Lewitt [États-Unis] ; Wolfgang Oertel [Allemagne] ; Niall Quinn [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie]	Identification of motor and nonmotor wearing‐off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment
001516 (2005)	Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Hughes [Australie] ; Andrew Evans [Royaume-Uni] ; Alice J. Manson [Royaume-Uni] ; Marion Hoffman [Australie] ; Lesley Swinn [Royaume-Uni] ; Hilary Watt [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]	Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challenges
001613 (2004)	C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie]	Levodopa in the treatment of Parkinson's disease: Current controversies
001C39 (2000)	Anette Schrag [Royaume-Uni] ; Niall Quinn [Royaume-Uni]	Dyskinesias and motor fluctuations in Parkinson's disease
001E46 (1998)	Anette Schrag [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] ; Richard Brown [Royaume-Uni] ; C. David Marsden [Royaume-Uni] ; Niall Quinn [Royaume-Uni]	Young‐onset Parkinson's disease revisited—clinical features, natural history, and mortality
002910 (1987)	Niall Quinn [Royaume-Uni] ; Peter Critchley [Royaume-Uni] ; Marsden [Royaume-Uni]	Young onset Parkinson's disease

---

List of associated KwdEn.i

Nombre de documents	Descripteur
6	Parkinson's disease
2	dyskinesias
2	levodopa
2	motor fluctuations
1	ARSAC = Administration of Radioactive Substances Advisory Committee
1	Dyskinesias
1	F-dopa PET = 18F-dopa positron emission tomography
1	Juvenile
1	Juvenile parkinsonism
1	LOD = logarithm of the odds
1	LRRK2
1	LRRK2 = leucine-rich, repeat kinase 2
1	Levodopa therapy
1	Lewy bodies
1	NFTs = neurofibrillary tangles
1	NHNN = National Hospital for Neurology and Neurosurgery
1	Parkinson's disease dementia
1	Response fluctuations
1	UPSIT = University of Pennsylvania Smell Identification Test
1	Young‐onset Parkinson's disease
1	apomorphine
1	cM = centimorgan
1	dardarin
1	dementia
1	diagnosis
1	diagnostic criteria
1	dyskinesia
1	motor complications
1	neurotoxicity
1	wearing‐off

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Niall Quinn" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Niall Quinn" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Niall Quinn
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024